How to buy Akers Biosciences stock

Akers Biosciences is a medical instruments & supplies business based in the US. Akers Biosciences shares (AKER) are listed on the NASDAQ and all prices are listed in US Dollars. Akers Biosciences employs 4 staff and has a trailing 12-month revenue of around $1.6 million.

Akers Biosciences stock price (NASDAQ: AKER)

Use our graph to track the performance of AKER stocks over time.

Akers Biosciences shares at a glance

• Key figures

Information last updated 2021-08-22.

Latest market close	$648.00
52-week range	$0.00 - $0.00
50-day moving average more info button	$6.49
200-day moving average more info button	$5.23
Wall St. target price	$4.00
PE ratio more info button	N/A
Dividend yield more info button	N/A (0%)
Earnings per share (TTM) more info button	$-0.72

Buy Akers Biosciences stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Akers Biosciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Akers Biosciences price performance over time

Historical closes compared with the close of $648 from 2021-05-31

1 week (2023-01-16)	N/A
1 month (2022-12-23)	N/A
3 months (2022-10-23)	N/A
6 months (2022-07-23)	N/A

1 year (2022-01-23)	N/A
2 years (2021-01-27)	23,209.35%
3 years (2020-01-27)	22,016.04%
5 years (2018-01-26)	272,168.91%

Akers Biosciences financials

Revenue TTM	$1.6 million
Gross profit TTM	$478,747
Return on assets TTM	-32.18%
Return on equity TTM	-55.32%
Profit margin	0%
Book value	$3.92
Market capitalisation more info button	$20.6 million

TTM: trailing 12 months

Akers Biosciences share dividends

We're not expecting Akers Biosciences to pay a dividend over the next 12 months.

Have Akers Biosciences's shares ever split?

Akers Biosciences's shares were split on a 1:24 basis on 25 November 2019. So if you had owned 24 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Akers Biosciences shares – just the quantity. However, indirectly, the new 2300% higher share price could have impacted the market appetite for Akers Biosciences shares which in turn could have impacted Akers Biosciences's share price.

Akers Biosciences share price volatility

Over the last 12 months, Akers Biosciences's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Akers Biosciences's is 0.3354. This would suggest that Akers Biosciences's shares are less volatile than average (for this exchange).

Akers Biosciences overview

Akers Biosciences, Inc. focuses on the development of a vaccine candidate against SARS-CoV-2, a coronavirus causing a pandemic. It has a collaboration agreement with Premas Biotech PVT Ltd. The company was incorporated in 1989 and is headquartered in New York, New York. .

Frequently asked questions

What percentage of Akers Biosciences is owned by insiders or institutions?
Currently 12.511% of Akers Biosciences shares are held by insiders and 13.406% by institutions. How many people work for Akers Biosciences?
Latest data suggests 4 work at Akers Biosciences. When does the fiscal year end for Akers Biosciences?
Akers Biosciences's fiscal year ends in December. Where is Akers Biosciences based?
Akers Biosciences's address is: 1185 Avenue of the Americas, New York, NY, United States, 10036 What is Akers Biosciences's ISIN number?
Akers Biosciences's international securities identification number is: US62856X1028 What is Akers Biosciences's CUSIP number?
Akers Biosciences's Committee on Uniform Securities Identification Procedures number is: 00973E409